*ST海利 (603718.SH) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−3.6x

Market Cap

CNY 1.90B

MomentumView details →

1D Return

−2.01%

YTD Return

−48.03%

RSI (14)

60.5

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−3.6x

Market Cap

CNY 1.90B

RSI (14)

60.5

MomentumView details →

1D Return

−2.01%

YTD Return

−48.03%

ProfitabilityView details →

Gross Margin

68.77%

Net Margin

−182.17%

EBITDA Margin

−327.55%

ROE (TTM)

−35.65%

ROA (TTM)

−25.30%

Asset Turnover

0.15x

GrowthView details →

Revenue YoY

−33.92%

EPS YoY

—

FCF YoY

+71.84%

Revenue CAGR 3Y

−14.44%

EPS CAGR 3Y

—

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.10x

Current Ratio

4.27x

Quick Ratio

3.76x

Div Yield

—

Div Rate

—

Div Growth 1Y

+173.17%

Financials snapshotView financials →

Revenue (TTM)

173.47M

Net Income (TTM)

−316.00M

Op. CF (TTM)

68.11M

Latest newsMore news →

No recent news for 603718.SH.

Similar companies

Braveheart Bio, Inc.BRVE Stoke Therapeutics, Inc.STOK Vir Biotechnology, Inc.VIR GH Research PLCGHRS Galapagos N.V. Sponsored ADRLKFT Recursion Pharmaceuticals, Inc.RXRX Find similar companies →

Latest newsMore news →

No recent news for 603718.SH.